Noscapine and Apoptosis in Breast and Other Cancers.

Abstract

Breast cancer is the second leading contributor to the age-standardized mortality rate, for both sexes and all ages worldwide. In Europe and the United States, it is the second leading cause of mortality, with an incidence rate of about 2.6 million cases per year. Noscapine, a well-known alkaloid used as a cough suppressant, demonstrated anti-tumor effects by triggering apoptosis in various cancer cell lines and has the potential to become another ally against breast, ovarian, colon, and gastric cancer, among other types of malignancy. Apoptosis plays a crucial role in the treatment of cancer. Noscapine affected BAX, CASP8, CASP9, NFKBIA, and RELA gene and protein expression in the MCF-7 and MDA-MB-231 cell lines. Gene expression was higher in tumor than in normal tissue, including the BAX expression levels in lung, ovary, endometrium, colon, stomach, and glioblastoma patients; BCL2L1 expression in endometrium, colon, and stomach patients; CASP8 gene expression levels in lung, endometrium, colon, stomach, and glioblastoma patients; RELA in colon, stomach, and glioblastoma patients; and NFKBIA in glioblastoma patients. It can be concluded that noscapine affected genes and proteins related to apoptosis in cancer cell lines and several types of cancer patients.

• Authors: Gloria M Calaf, Leodan A Crispin, Edwin O Quisbert-Valenzuela
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 25 Issue 6 (Mar 21 2024) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 38542508 (Publication Type: Journal Article, Review)

Chemical References

• Noscapine
• bcl-2-Associated X Protein
• Antineoplastic Agents

Topics

• Male
• Female
• Humans
• Noscapine (pharmacology)
• bcl-2-Associated X Protein (metabolism)
• Glioblastoma
• Apoptosis (genetics)
• Antineoplastic Agents (pharmacology)
• Breast Neoplasms (pathology)
• Cell Line, Tumor
• Cell Proliferation